Genetically modified
View Patent ↗Recombinant attenuated Y. pseudotuberculosis mutants have been created that show efficacy as oral vaccines against plague caused by Y. pestis and Yersinosis caused by both Y. enterocolitica and Y. pseudotuberculosis . Thus, live attenuated Y. pseudotuberculosis -based vaccines can be used to prevent Yersinosis in farm animals such as swine, cattle and sheep. The palatable baits containing live attenuated Y. pseudotuberculosis -based vaccines may be acceptable methods to control plague epidemics in wild animals. The methods disclosed can also be used to generate recombinant attenuated Y. entercolitica and Y. pestis vaccine strains.
1. A recombinant attenuated Yersinia pseudotuberculosis bacterium, wherein the bacterium comprises Δasd, wherein the bacterium delivers a YopE Nt138 -LcrV fusion protein (N-terminal portion of YopE fused with LcrV of Y. pestis ) by a Type 3 secretion system; and wherein the bacterium is capable of eliciting protective immune responses against plague caused by Y. pestis and Yersinosis caused by Y. enterocolitica or Y. pseudotuberculosis in a host.
2. A vaccine comprising a recombinant bacterium of claim 1 .
3. The vaccine of claim 2 , wherein the vaccine elicits a protective immune response against plague caused by Y. pestis and Yersinosis caused by either Y. enterocolitica or Y. pseudotuberculosis.
4. A method of inducing an immune response in a host, the method comprising administering a bacterium of claim 1 though bait to the host.
5. The method of claim 4 , wherein the immune response is a protective immune response.